Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jinqiong Jiang"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundMetabolic syndrome (MetS) has been related to a high incidence of hepatocellular carcinoma (HCC). However, the influence of MetS on survival of patients with HCC is still unclear. We performed a systematic review and meta-analysis to evalua
Externí odkaz:
https://doaj.org/article/599cf9be59fc41f3b7740a627fd0a2bc
Autor:
Gaoying Kong, Jinqiong Jiang, Jia Zhou, Chuang Peng, Yinghui Song, Meng Fang, Bo Jiang, Hao Li, Lei Zhou, Chen Chen, Sulai Liu, Bao Zhang, Yongzhi Chen
Publikováno v:
Journal of Cancer
Accumulated studies showed that numerous microRNAs (miRNAs) were aberrantly expressed in human intrahepatic cholangiocarcinoma (ICC) and contributed to the tumorigenic processes. However, whether miR-129-2-3p is implicated in the ICC initiation and p
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 2, Pp 11847-11857 (2021)
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 2, Pp 11847-11857 (2021)
Blockage of phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signal pathway is effective to increase the cytotoxic effects of oncolytic virus on cancer cells, but the detailed mechanisms are still largely unknown. Based on this, the present st
Autor:
Chuang Peng, Linsheng Huang, Hao Li, Jinqiong Jiang, Bo Jiang, Nanhui Yu, Xiehong Liu, Yuan Lv, Yu Jiang, Xing Yu, Lianhong Zou, Sulai Liu
Publikováno v:
Cancer Management and Research. 11:8005-8022
Background Inducible nitric oxide synthase (iNOS) has supposed to implicate in inflammation, infection, liver cirrhosis, and neoplastic diseases. This study was designed to explore the biological and clinical function of iNOS in intrahepatic cholangi
Autor:
Jinqiong Jiang1, Yiping Liu1, Youhong Tang1, Li Li1, Ruolan Zeng1, Shan Zeng1, Meizuo Zhong1 zhongmeizuo2015@126.com
Publikováno v:
OncoTargets & Therapy. Aug2016, Vol. 9, p5349-5360. 12p.
Publikováno v:
Biochemical and Biophysical Research Communications.
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpoli
Publikováno v:
OncoTargets and therapy
Jinqiong Jiang, Yiping Liu, Youhong Tang, Li Li, Ruolan Zeng, Shan Zeng, Meizuo Zhong Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China Abstract: Increasing evidence has shown that aldeh
Autor:
Yinghui Song, Li Li, Youhong Tang, Meizuo Zhong, Yiping Liu, Pingyong Yi, Jinqiong Jiang, Ping-ping Gan
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 35(12)
Although there have been substantial advances in our knowledge of the resistance of diffuse large B cell lymphoma (DLBCL) to chemotherapy, there are few efficient treatment strategies for recurrent/refractory DLBCL. The aim of this study was to inves